Nettle™ & PMDD: What the Research Says + Q&A

Nettle™ & PMDD: What the Research Says + Q&A with Samphire Neuroscience CEO, Emilė Radytė

When: November 6, 2025 at 12 PM ET/ 5 PM GMT

Ticket Price: $15.00 + Eventbrite fees

Please note: Eventbrite has decided not to implement in-app purchases for paid online events. This means tickets must be purchased from a web browser on desktop or mobile. We apologize for the inconvenience.

Event Description:

This webinar will explore new research into non-invasive brain stimulation for Premenstrual Dysphoric Disorder (PMDD). We will review the recent study Validation of a Non-Invasive Brain Stimulation Device (Nettle™) to Manage Symptoms of PMDD and discuss what it means for future treatment options.

Following the review, participants attending live have the opportunity to take part in a Q&A with Emilé Radyte, PhD, CEO & Founder of Samphire Neuroscience, and inventor of the Nettle™ device.

After this session, you will:

• Understand the neuroscience of PMDD, including the latest research on how cyclical hormone sensitivity impacts brain function and emotional regulation.
• Understand the key barriers to accurate PMDD diagnosis, including the need for cycle tracking and symptom overlap with other conditions like ADHD and bipolar disorder.
• Evaluate the potential role of the Nettle™ device as a non-invasive, non-hormonal, and non-medication treatment option for PMDD, especially for those who don't respond well to current therapies. This will include an exploration of results from a recent clinical trial assessing Nettle specifically for PMDD, where it is currently approved for pain and mood symptoms.
• Identify the challenges and opportunities in integrating new PMDD treatments like Nettle™ into healthcare systems, including the importance of clinician awareness, patient advocacy, and coordinated care pathways.

Intended Audience:
Designed for anyone who wants to better understand PMDD with an interest in research, mental health, and emerging health technologies.

Hosted by:

IAPMD and Emilė Radytė, PhD - CEO & Founder of Samphire Neuroscience.

Thanks to the generous support of the Christina Bohn Foundation, we’re able to offer a limited number of complimentary tickets to help make this event accessible to everyone who wishes to join. Please reach out to events@iapmd.org for more information.

Will this be recorded?

Yes, this event will be recorded and a link will be shared with all who register.